CHRISTINE COYLE: Open Payments
NPI 1043626567 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,623 in 90 payments from 20 companies in 2025. Trend: 2023 $1,726 · 2024 $2,395 · 2025 $1,623
Food & beverage: $1,623
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $328 |
| AstraZeneca Pharmaceuticals LP | 6 | $205 |
| Lilly USA, LLC | 11 | $186 |
| ABBVIE INC. | 11 | $161 |
| Exact Sciences Corporation | 5 | $122 |
| Corcept Therapeutics | 6 | $96 |
| PFIZER INC. | 5 | $96 |
| Astellas Pharma US Inc | 4 | $67 |
| Amneal Pharmaceuticals LLC | 3 | $52 |
| Madrigal Pharmaceuticals | 2 | $51 |
Products named: Rybelsus, FARXIGA, Wegovy, Korlym, MOUNJARO, VRAYLAR, Cologuard Collection Kit, Ozempic.
Industry payments across NJ — which companies pay providers there.
